CONTRAVISORY INVESTMENT MANAGEMENT, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 179 filers reported holding HAEMONETICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CONTRAVISORY INVESTMENT MANAGEMENT, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$292,479
+6.4%
3,265
+1.1%
0.08%
+13.7%
Q2 2023$274,832
+2.9%
3,2280.0%0.07%
-2.7%
Q1 2023$267,117
+4092.7%
3,228
+3885.2%
0.08%
+3650.0%
Q4 2022$6,371
+6.2%
810.0%0.00%0.0%
Q3 2022$6,000
+20.0%
810.0%0.00%0.0%
Q2 2022$5,000
-97.2%
81
-98.5%
0.00%
-95.2%
Q3 2015$178,000
-21.6%
5,5000.0%0.04%
-14.3%
Q2 2015$227,000
-8.1%
5,5000.0%0.05%
-2.0%
Q1 2015$247,0005,5000.05%
Other shareholders
HAEMONETICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders